Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes ...

Samsung might be the first to crack the non-invasive blood glucose monitoring code, but gaining FDA approval will be the ...

Samsung held a Health Forum in San Jose the day after Unpacked, where its senior vice president Hon Pak spoke about an old rumor: non-invasion glucose monitoring. According to Android Authority, Pak ...

With continuous glucose monitors, students with Type 1 diabetes no longer have to visit the school nurse for a finger prick. But some parents say it falls to them to keep an eye on blood sugar levels ...

With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced compelling ...

The global point of care diagnostics market valued at US$ 14.26 billion in 2023, is forecasted to grow at a robust CAGR of ...

India is at a crossroads in its health journey, with over 50% of diabetes cases remaining undiagnosed and rising rates of stress-induced hypertension and obesity. The Dr. Morepen Sync Mobile App comes ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its ...

But what exactly is driving this sudden attention towards Trinity Biotech, and how does it compare to broader market trends? Let’s explore. Trinity Biotech is a commercial-stage biotechnology company ...

The bookseller is applying its sales model—where online purchases support indie bookstores—to digital books. It has also ...